← FDA Drug Approvals (Drugs@FDA)

ERIBULIN MESYLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: DR REDDYS · Approved 2025-07-03

Drug application

FDA Application #
ANDA217473
Application type
Abbreviated New Drug Application (Generic)
Brand name
ERIBULIN MESYLATE
Generic name
ERIBULIN MESYLATE
Active ingredients
ERIBULIN MESYLATE
Dosage form
SOLUTION
Route
INTRAVENOUS
Marketing status
Prescription
Sponsor
DR REDDYS
Manufacturer
Dr. Reddys Laboratories Inc
First approval
2025-07-03

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown